Search results
7 High-Yield Dividend Stocks That Work While You Sleep
InvestorPlace· 2 hours agoAlthough seemingly most of the celebrated ideas on financial publications center on high-growth...
What’s Going Around | CDC warns of new COVID variant: FLiRT
WDVM via Yahoo News· 4 days agoWASHINGTON (DC News Now) — Just in time for summer – there is a new COVID variant spreading. It’s...
How Moderna’s newly approved RSV vaccine could impact 2024 revenue - Boston Business Journal
The Business Journals· 1 day agoOn Friday, Moderna Inc. (Nasdaq: MRNA) notched its second-ever FDA product approval, this time for...
Hope for global pandemic treaty rises — despite missed deadline
Nature· 2 days agoDelegates were at an impasse over key issues, but agreements on other public-health emergency...
Moderna Wins FDA Approval For Second-Ever Product; Why Its RSV Vaccine Could Dominate Pfizer, GSK
Investor's Business Daily· 4 days agoModerna's RSV vaccine is the only one that uses a pre-filled syringe. This makes the process of...
Cost and Vosevi: How to find savings, lower costs, and more
Medical News Today· 23 hours agoThe cost of the drug with and without insurance can depend on several factors, such as whether...
Moderna Investors Just Got Some Bullish News
Motley Fool via Yahoo Finance· 1 day agoSo investors today aren't viewing the vaccine as a growth product for the company. But this problem evaporated with the good news Moderna delivered a few...
Personalized Phage Therapy Heals Cat With Deadly Bacterial Infection
Forbes· 5 days agoA persistent infection in a pet cat’s leg after a compound fracture was repaired has finally been...
Feds plan for smoother access to RSV infant shot
Politico· 6 days agoFIRST IN RxP: PCMA PRIMES YEAR-END DEBATE — The Pharmaceutical Care Management Association, the industry group for pharmacy benefit managers, is launching a six-figure summer ...
Moderna wins FDA approval for RSV vaccine
BioPharma Dive via Yahoo Finance· 4 days agoThe OK for mResvia adds another option for preventing RSV-related disease in older adults, one year after the agency cleared shots from GSK and Pfizer.